Discover
CYCN
Cyclerion Therapeutics, Inc.
3.58
2 x 3.51
1 x 3.64
bid
ask
+
0.01
0.28%
1 @ 04:00 PM
3.58 +0.00 (0.00%)
| Ytd | 181.89% | |
| 1y | 56.33% |
3.51
day range
3.73
1.03
52 week range
8.48
| Open | 3.51 | Prev Close | 3.57 | Low | 3.51 | High | 3.73 | Mkt Cap | 16.76M |
| Vol | 8.21K | Avg Vol | 30.16K | EPS | -1.15 | P/E | -3.11 | Forward P/E | -2.44 |
| Beta | 1.92 | Short Ratio | 0.78 | Inst. Own | 40.41% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 3.39 | 200-d Avg | 2.33 | 1yr Est | 4.00 |
| Income Statement | |||
| Operating Expenses | 1.77M | ||
| Selling, General and Administrative Expense | 1.77M | ||
| Operating Income | -1.77M | ||
| Net Income | -1.75M | ||
| Net Income Common Stock | -1.75M | ||
| Net Income Common Stock (USD) | -1.75M | ||
| Consolidated Income | -1.75M | ||
| Earnings per Basic Share | -0.41 | ||
| Earnings per Basic Share (USD) | -0.41 | ||
| Earnings per Diluted Share | -0.41 | ||
| Earning Before Interest & Taxes (EBIT) | -1.75M | ||
| Earning Before Interest & Taxes (USD) | -1.75M | ||
| Weighted Average Shares | 4.25M | ||
| Weighted Average Shares Diluted | 4.25M | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.39M | ||
| Cash and Equivalents (USD) | 1.39M | ||
| Investments | 5.35M | ||
| Investments Non-Current | 5.35M | ||
| Current Assets | 1.51M | ||
| Property, Plant & Equipment Net | 66.00K | ||
| Total Assets | 6.93M | ||
| Current Liabilities | 1.84M | ||
| Total Liabilities | 1.84M | ||
| Accumulated Retained Earnings (Deficit) | -275.95M | ||
| Shareholders Equity | 5.09M | ||
| Shareholders Equity (USD) | 5.09M | ||
| Assets Non-Current | 5.42M | ||
| Trade and Non-Trade Payables | 1.60M | ||
| Cash Flow | |||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.43M | ||
| Net Cash Flow from Operations | -1.43M | ||
| Share Based Compensation | 51.00K | ||